Neo Ivy Capital Management’s AbbVie ABBV Stock Holding History

Neo Ivy Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,754	Closed	-$401K	–	316
2025 Q4	$401K	Buy	+1,754	New	+$400K	0.06%	215
2025 Q2	–	Sell	-896	Closed	-$188K	–	345
2025 Q1	$188K	Buy	+896	New	+$174K	0.06%	222
2023 Q3	–	Sell	-894	Closed	-$120K	–	308
2023 Q2	$120K	Buy	+894	New	+$131K	0.06%	231
2022 Q4	–	Sell	-1,174	Closed	-$158K	–	313
2022 Q3	$158K	Buy	+1,174	New	+$168K	0.42%	93
2022 Q2	–	Sell	-546	Closed	-$88K	–	383
2022 Q1	$88K	Buy	+546	New	+$79.3K	0.08%	317
2021 Q3	–	Sell	-2,222	Closed	-$250K	–	439
2021 Q2	$250K	Sell	2,222 -1,480	-40%	-$167K	0.25%	149
2021 Q1	$401K	Buy	+3,702	New	+$396K	0.44%	69
2020 Q4	–	Sell	-4,514	Closed	-$395K	–	400
2020 Q3	$395K	Buy	+4,514	New	+$425K	0.4%	79
2020 Q2	–	Sell	-3,253	Closed	-$248K	–	440
2020 Q1	$248K	Sell	3,253 -421	-11%	-$35.9K	0.4%	82
2019 Q4	$325K	Buy	+3,674	New	+$305K	0.38%	120
2019 Q3	–	Sell	-3,214	Closed	-$234K	–	273
2019 Q2	$234K	Sell	3,214 -7,155	-69%	-$562K	0.13%	197
2019 Q1	$835K	Buy	+10,369	New	+$848K	0.47%	95

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neo Ivy Capital Management's ABBV Position: Q1 2026 in Review

Neo Ivy Capital Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,754 shares — an estimated $401K sold.

Neo Ivy Capital Management first reported a position in ABBV in Q1 2019 and held it in 12 quarters. The position peaked at $835K in Q1 2019. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Neo Ivy Capital Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Neo Ivy Capital Management sold 1,754 AbbVie shares in Q1 2026, an estimated $401K.
Neo Ivy Capital Management first reported a position in AbbVie in Q1 2019 and held it in 12 quarters.
Neo Ivy Capital Management's AbbVie position peaked at $835K in Q1 2019.
4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.